The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma

The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma

Treatment of patients with COVID-19 using convalescent plasma from recently recovered patients has been shown to be safe, but the time course of change in clinical status following plasma transfusion in relation to baseline disease severity has not yet been described. We analyzed short, descriptive...

Full description

Bibliographic Details
Main Authors: Tengfei Ma, Chad C. Wiggins, Breanna M. Kornatowski, Ra'ed S. Hailat, Andrew J. Clayburn, Winston L. Guo, Patrick W. Johnson, Jonathon W. Senefeld, Stephen A. Klassen, Sarah E. Baker, Katelyn A. Bruno, DeLisa Fairweather, R. Scott Wright, Rickey E. Carter, Chenxi Li, Michael J. Joyner, Nigel S. Paneth
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Medicine
Subjects:
convalescent plasma therapy
antibody therapy
SARS-CoV-2
COVID-19
antibodies
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.707895/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.707895/full

Similar Items